Eye health company Bausch + Lomb's affiliate acquires Elios Vision [Yahoo! Finance]
Bausch + Lomb Corporation (BLCO)
Company Research
Source: Yahoo! Finance
The acquisition strengthens Bausch + Lomb's existing portfolio of surgical and pharmaceutical glaucoma treatments. Leerink Partners acted as exclusive financial adviser to Elios Vision for the acquisition while Wilson Sonsini Goodrich & Rosati, Professional Corporation provided legal counsel. Elios Vision developed ELIOS, a minimally invasive glaucoma surgery (MIGS) procedure that leverages an excimer laser technology to generate microscopic openings in the trabecular meshwork. This facilitates the outflow of aqueous and helps to reduce intraocular pressure. The procedure is the first to be clinically validated and can be performed along with cataract surgery. Elios Vision former chairman and CEO Elliot Friedman said: “Bausch + Lomb's extensive reach in cataract surgery will introduce ELIOS to a broader range of eye care professionals and help change the treatment paradigm for the estimated 80 million people worldwide living with glaucoma. “The goal is to make combining cat
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Contact lens maker Bausch + Lomb says it is exploring sale [Yahoo! Finance]Yahoo! Finance
- Stuart Therapeutics Announces the Appointment of Two New Board Members [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Confirms It Is Exploring a Potential Sale [BNN Bloomberg (Canada)]BNN Bloomberg
BLCO
Earnings
- 10/30/24 - Beat
BLCO
Sec Filings
- 12/26/24 - Form 4
- 12/26/24 - Form 4
- 12/26/24 - Form 4
- BLCO's page on the SEC website